Compare CVS Health Corp (CVS) vs Quest Diagnostics Inc (DGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Quest Diagnostics Inc — how do they compare? CVS Health Corp trades at $104.86 (market cap $135.48B), while Quest Diagnostics Inc trades at $205.45 (market cap $22.80B). The key difference: CVS Health Corp is far larger — about 5.9× Quest Diagnostics Inc's market cap, and CVS Health Corp pays the higher dividend (2.51%). Which is the better fit depends on your goals.
| CVS | DGX | |
|---|---|---|
Market Cap | $135.48B | $22.80B |
Sector | Health | Health |
52-Week High | $106.18 | $216.02 |
52-Week Low | $58.75 | $166.42 |
Enterprise Value | $202.02B | $28.82B |
Dividend Yield | 2.51% | 1.67% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →
